Subscribe

CleanSpace Holdings Limited (CSX.AX)

AUD0.40 +0.00 (+0.00%)
AU ASX Healthcare Medical - Devices
Address Unit 5 2065
St Leonards, NSW, AU
CEO Gabrielle O'Carroll
Website cleanspacetechnology.com
IPO 2020-10-22
ISIN AU0000107831

Explore sections of this company profile

Description

CleanSpace Holdings Limited is a global enterprise focused on the design, manufacturing, and sale of personal respiratory protective equipment and related services. The company's advanced solutions serve healthcare professionals and a wide array of industrial employers worldwide. Their key offerings include CleanSpace HALO, specifically designed for medical and healthcare environments; CleanSpace ULTRA, providing robust face, eye, and water-resistant protection; CleanSpace2, a versatile respirator for general industrial settings; and CleanSpace EX, engineered for safe operation in potentially explosive atmospheres. Furthermore, CleanSpace supplies an extensive range of accessories and consumable products, such as various masks, replacement filters, charging and storage solutions, specialized biohoods, adaptors, identification elements, headgear components, protective visors, and essential spare parts. This protective gear is deployed across diverse and demanding sectors, including mining, welding, construction, laboratories, dental practices, wastewater management, and critical healthcare and first responder roles. Founded in 2009, CleanSpace Holdings Limited maintains its headquarters in St Leonards, Australia.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
AUD0.40 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
23.2K
Beta
0.62
Float Shares
41.28M
Free Float %
50.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+2.67% -3.75% -11.49% -32.46% -40.77% -43.38% -10.47% +28.33% -79.08% -94.81% -94.81%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.40
Ratings Trend (MoM)
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
4.07
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
1 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Devices: +11.2%
    +25.7% ★ Q4'25: +38.1% (vs Q4'23)
  • ✗
    EPS growth Medical - Devices: +28.5%
    +84.9% ★ Q4'25: +188.3% (vs Q4'23)
  • ✗
    FCF margin FCF growth · Medical - Devices: +30.9%
    -8.2% Q4'25: -4.4% (vs Q4'23)
  • ✗
    EBIT margin Medical - Devices: +6.2%
    -6.5% Q4'25: -15.6% (vs Q4'23)
  • ✗
    ROIC Medical - Devices: +3.3%
    -9.7% Q4'25: -43.7% (vs Q4'23)
  • ✗
    Share dilution Medical - Devices: 0.0%
    +0.8% Q4'25: +1.4% (vs Q4'23)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    -5.50× Q4'25: -1.00× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.63) × ERP
WACC = 87% × Ke + 13% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 0.40
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Jun 2021
actual 		Jun 2022
actual 		Jun 2023
actual 		Jun 2024
actual 		Jun 2025
actual 		Jun 2026
1 Rev. Ana.
1 EPS Ana. 		Jun 2027
1 Rev. Ana.
1 EPS Ana. 		Jun 2028
1 Rev. Ana.
1 EPS Ana. 		Jun 2029
1 Rev. Ana.
Revenue
49.93M
est: 51.95M (-3.9%)
13.36M
est: 15.10M (-11.5%)
12.09M
est: 11.30M (+7.0%)
15.72M
est: 13.40M (+17.3%)
19.76M
est: 19.70M (+0.3%)
20.60M
20.60M – 20.60M
+4.6% YoY
24.40M
24.40M – 24.40M
+18.4% YoY
28.60M
28.60M – 28.60M
+17.2% YoY
33.00M
33.00M – 33.00M
+15.4% YoY
EBITDA
17.15M
est: -18.62M (+192.1%)
-14.10M
est: -5.41M (-160.5%)
-10.55M
est: -4.05M (-160.3%)
-3.49M
est: -4.80M (+27.3%)
-824.6K
est: -7.06M (+88.3%)
-7.38M
-7.38M – -7.38M
-4.6% YoY
-8.75M
-8.75M – -8.75M
-18.4% YoY
-10.25M
-10.25M – -10.25M
-17.2% YoY
-11.83M
-11.83M – -11.83M
-15.4% YoY
EBIT
15.97M
est: -20.63M (+177.4%)
-15.12M
est: -6.00M (-152.2%)
-11.59M
est: -4.49M (-158.2%)
-4.45M
est: -5.32M (+16.4%)
-1.28M
est: -7.82M (+83.6%)
-8.18M
-8.18M – -8.18M
-4.6% YoY
-9.69M
-9.69M – -9.69M
-18.4% YoY
-11.35M
-11.35M – -11.35M
-17.2% YoY
-13.10M
-13.10M – -13.10M
-15.4% YoY
Net Income
11.39M
est: 11.99M (-5.0%)
-11.28M
est: -12.61M (+10.6%)
-8.13M
est: -11.21M (+27.5%)
-3.13M
est: -7.63M (+59.0%)
-478.3K
est: -420.5K (-13.8%)
-334.8K
-334.8K – -334.8K
+20.4% YoY
1.13M
1.13M – 1.13M
+437.2% YoY
2.62M
2.62M – 2.62M
+132.4% YoY
—
— – —
-100.0% YoY
SGA
19.70M
est: 47.13M (-58.2%)
21.19M
est: 13.70M (+54.7%)
17.48M
est: 10.25M (+70.5%)
13.62M
est: 12.16M (+12.0%)
4.82M
est: 17.87M (-73.0%)
18.69M
18.69M – 18.69M
+4.6% YoY
22.14M
22.14M – 22.14M
+18.4% YoY
25.95M
25.95M – 25.95M
+17.2% YoY
29.94M
29.94M – 29.94M
+15.4% YoY
EPS
0.15
est: 0.15 (-2.6%)
-0.15
est: -0.16 (+7.4%)
-0.11
est: -0.14 (+23.6%)
-0.04
est: -0.10 (+58.7%)
-0.01
est: -0.01 (-13.0%)
0.00
0.00 – 0.00
+20.4% YoY
0.01
0.01 – 0.01
+437.2% YoY
0.03
0.03 – 0.03
+132.4% YoY
—
— – —
-100.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-27 A- 4/5 4/5 4/5 5/5 3/5 1/5 3/5
2026-05-26 A- 4/5 4/5 4/5 5/5 3/5 1/5 3/5
2026-05-25 A- 4/5 4/5 4/5 5/5 3/5 1/5 3/5
2026-05-22 A- 4/5 4/5 4/5 5/5 3/5 1/5 3/5
2026-05-20 A- 4/5 4/5 4/5 5/5 3/5 1/5 3/5
2026-05-18 A- 4/5 4/5 4/5 5/5 3/5 2/5 3/5
2026-05-15 A- 4/5 4/5 4/5 5/5 3/5 2/5 3/5
2026-05-14 A- 4/5 4/5 4/5 5/5 3/5 2/5 3/5
2026-05-13 A- 4/5 3/5 4/5 5/5 3/5 2/5 3/5
2026-05-11 A- 4/5 3/5 4/5 5/5 3/5 2/5 3/5
2026-05-08 B+ 3/5 3/5 3/5 5/5 3/5 2/5 3/5
2026-05-07 B+ 3/5 3/5 3/5 5/5 3/5 2/5 3/5
2026-05-06 B+ 3/5 3/5 3/5 5/5 3/5 2/5 3/5
2026-05-05 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-05-04 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-05-01 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-30 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-29 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-27 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-24 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-23 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-22 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-20 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5
2026-04-17 B+ 3/5 3/5 3/5 5/5 2/5 2/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
2.06M
OE per share TTM
0.03
Owner's Yield
7.04%
Maintenance CapEx ratio
14.10%
Maint CapEx / Avg PPE
11.9%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-23.3K
Shares Outstanding
82.18M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Dan Kao Director of Innovation & Operations and Executive Director 337.7K male
Gabrielle O'Carroll Chief Executive Officer 330.6K female
Bree Greeff Chief Financial Officer 302.5K female
Elissa Hansen Company Secretary — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices